HHLA2 and liver cancer: We revealed that high HHLA2 expression indicated worse outcome in early-stage of Barcelona Clinic Liver Cancer staging system (BCLC) (overall survival: P=0.0010; TTR: P=0.0044; Supplementary Figure 1C).